Zhejiang Liaoyuan Pharmaceutical Co LTD
CEP Certificates (EDQM COS List)

Zhejiang Liaoyuan Pharmaceutical Co LTD

CEP Database

Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.

Chemical China
  • Total Records 7
  • Latest End Date -
  • Data Source EDQM
  • Last Updated 2025-05-23
Company Overview

Company

Zhejiang Liaoyuan Pharmaceutical Co LTD

Country

China

Company Snapshot

Zhejiang Liaoyuan Pharmaceutical Co LTD

9-3f, Jingjiang Huacheng

China

www.liaoyuan.com.cn/ alanzp@liaoyuan.com.cn View on Map
CEP Records Timeline (7 records)
2025
23 May
Chemical Valid

Product

Mirtazapine, Anhydrous

Substance

ZHEJIANG LIAOYUAN PHARMACEUTICAL CO., LTD. Duqiao Town CN

Certificate No.

CEP 2020-158 - Rev 02

Substance No.

2338

Issue Date

2025-05-23

End Date

-

Country

China

Identifiers

Certificate No.: CEP 2020-158 - Rev 02
Substance No.: 2338

2022
13 Jan
Chemical Valid

Product

Clopidogrel hydrogen sulfate, Process C

Substance

ZHEJIANG LIAOYUAN PHARMACEUTICAL CO., LTD. Duqiao Town CN

Certificate No.

R0-CEP 2021-414 - Rev 00

Substance No.

2531

Issue Date

2022-01-13

End Date

-

Country

China

Identifiers

Certificate No.: R0-CEP 2021-414 - Rev 00
Substance No.: 2531

2021
09 Sep
Chemical Valid

Product

Clopidogrel hydrogen sulfate, Process B

Substance

ZHEJIANG LIAOYUAN PHARMACEUTICAL CO., LTD. Duqiao Town CN

Certificate No.

R0-CEP 2020-159 - Rev 00

Substance No.

2531

Issue Date

2021-09-09

End Date

-

Country

China

Identifiers

Certificate No.: R0-CEP 2020-159 - Rev 00
Substance No.: 2531

2021
15 Jul
Chemical Valid

Product

Clopidogrel hydrogen sulfate

Substance

ZHEJIANG LIAOYUAN PHARMACEUTICAL CO., LTD. Duqiao Town CN

Certificate No.

R1-CEP 2015-156 - Rev 00

Substance No.

2531

Issue Date

2021-07-15

End Date

-

Country

China

Identifiers

Certificate No.: R1-CEP 2015-156 - Rev 00
Substance No.: 2531

2021
03 May
Chemical Valid

Product

Ticlopidine hydrochloride

Substance

ZHEJIANG LIAOYUAN PHARMACEUTICAL CO., LTD. Duqiao Town CN

Certificate No.

R1-CEP 2004-109 - Rev 03

Substance No.

1050

Issue Date

2021-05-03

End Date

-

Country

China

Identifiers

Certificate No.: R1-CEP 2004-109 - Rev 03
Substance No.: 1050

2020
28 Aug
Chemical Valid

Product

Duloxetine hydrochloride

Substance

ZHEJIANG LIAOYUAN PHARMACEUTICAL CO., LTD. Duqiao Town CN

Certificate No.

R1-CEP 2014-239 - Rev 00

Substance No.

2594

Issue Date

2020-08-28

End Date

-

Country

China

Identifiers

Certificate No.: R1-CEP 2014-239 - Rev 00
Substance No.: 2594

2019
08 Mar
Chemical Valid

Product

Mirtazapine

Substance

ZHEJIANG LIAOYUAN PHARMACEUTICAL CO., LTD. Duqiao Town CN

Certificate No.

R1-CEP 2009-180 - Rev 02

Substance No.

2338

Issue Date

2019-03-08

End Date

-

Country

China

Identifiers

Certificate No.: R1-CEP 2009-180 - Rev 02
Substance No.: 2338

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
Official Source

All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).

Visit EDQM
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Country

China

Identifiers

Certificate No.: CEP 2020-158 - Rev 02
Substance No.: 2338

100% Official Data

Directly from the EDQM CEP database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

CEP data is obtained from the official EDQM (European Directorate for the Quality of Medicines) database.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.